Committee on Environment, Public Health and Safety I

by Elli Bazil (AT)

A hard pill to swallow: In an era marked by rapid advancements and innovations in the medical field, a stark reality persists: countless patients are still left behind due to the high cost and limited availability of essential medications. As the global demand for pharmaceuticals surges and the market continues to expand, what strategies can the EU implement to ensure that sustainable and accessible medications are available to all, regardless of their socioeconomic circumstances?